International Journal of High Risk Behaviors and Addiction

Published by: Kowsar

Mental Health Assessment in Patients Admitted to Iran Psychiatric Hospital with a Diagnosis of Psychosis Due to 2 - 5 Years of Methamphetamine Use

Hamid Reza Ahmadkhaniha 1 , Kaveh Alavi 2 , Elham Rouhi 1 , * and Mohammad Reza Najarzadegan 1
Authors Information
1 Research Centre for Addiction and Risky Behaviors (ReCARB), Department of Psychiatry, Iran University of Medical Sciences, Tehran, IR Iran
2 Mental Health Research Center, Department of Psychiatry, Iran University of Medical Sciences, Tehran, IR Iran
Article information
  • International Journal of High Risk Behaviors and Addiction: June 2018, 7 (2); e64561
  • Published Online: May 21, 2018
  • Article Type: Research Article
  • Received: November 28, 2017
  • Accepted: January 10, 2018
  • DOI: 10.5812/ijhrba.64561

To Cite: Ahmadkhaniha H R, Alavi K, Rouhi E, Najarzadegan M R. Mental Health Assessment in Patients Admitted to Iran Psychiatric Hospital with a Diagnosis of Psychosis Due to 2 - 5 Years of Methamphetamine Use, Int J High Risk Behav Addict. 2018 ; 7(2):e64561. doi: 10.5812/ijhrba.64561.

Copyright © 2018, International Journal of High Risk Behaviors and Addiction. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Bramness JG, Gundersen OH, Guterstam J, Rognli EB, Konstenius M, Loberg EM, et al. Amphetamine-induced psychosis--a separate diagnostic entity or primary psychosis triggered in the vulnerable? BMC Psychiatry. 2012;12:221. doi: 10.1186/1471-244X-12-221. [PubMed: 23216941]. [PubMed Central: PMC3554477].
  • 2. United nations secretariat secretary. General's bulletin organization of the united nations office on drugs and crime. 2004.
  • 3. Jaffe JH, Ling W, Rawson RA. Amphetamine (or amphetamine like)-related disorders. In: Sadock B, Sadock V, Pedro R, editors. Kaplan and sadock's comprehensive textbook of psychiatry. New York: Lippincott Williams and Wilkins; 2009.
  • 4. Fasihpour B, Molavi S, Shariat SV. Clinical features of inpatients with methamphetamine-induced psychosis. J Ment Health. 2013;22(4):341-9. doi: 10.3109/09638237.2012.745184. [PubMed: 23323572].
  • 5. Akiyama K, Saito A, Shimoda K. Chronic methamphetamine psychosis after long-term abstinence in Japanese incarcerated patients. Am J Addict. 2011;20(3):240-9. doi: 10.1111/j.1521-0391.2011.00124.x. [PubMed: 21477052].
  • 6. Kittirattanapaiboon P, Mahatnirunkul S, Booncharoen H, Thummawomg P, Dumrongchai U, Chutha W. Long-term outcomes in methamphetamine psychosis patients after first hospitalisation. Drug Alcohol Rev. 2010;29(4):456-61. doi: 10.1111/j.1465-3362.2010.00196.x. [PubMed: 20636664].
  • 7. Ikeda M, Okahisa Y, Aleksic B, Won M, Kondo N, Naruse N, et al. Evidence for shared genetic risk between methamphetamine-induced psychosis and schizophrenia. Neuropsychopharmacology. 2013;38(10):1864-70. doi: 10.1038/npp.2013.94. [PubMed: 23594818]. [PubMed Central: PMC3746703].
  • 8. Callaghan RC, Cunningham JK, Allebeck P, Arenovich T, Sajeev G, Remington G, et al. Methamphetamine use and schizophrenia: a population-based cohort study in California. Am J Psychiatry. 2012;169(4):389-96. doi: 10.1176/appi.ajp.2011.10070937. [PubMed: 22193527].
  • 9. Sulaiman AH, Said MA, Habil MH, Rashid R, Siddiq A, Guan NC, et al. The risk and associated factors of methamphetamine psychosis in methamphetamine-dependent patients in Malaysia. Compr Psychiatry. 2014;55 Suppl 1:S89-94. doi: 10.1016/j.comppsych.2013.01.003. [PubMed: 23433219].
  • 10. Lecomte T, Mueser KT, MacEwan W, Thornton AE, Buchanan T, Bouchard V, et al. Predictors of persistent psychotic symptoms in persons with methamphetamine abuse receiving psychiatric treatment. J Nerv Ment Dis. 2013;201(12):1085-9. doi: 10.1097/NMD.0000000000000059. [PubMed: 24284645].
  • 11. Mehrjerdi ZA, Abarashi Z, Noroozi A, Arshad L, Zarghami M. Correlates of shared methamphetamine injection among methamphetamine-injecting treatment seekers: the first report from Iran. Int J STD AIDS. 2014;25(6):420-7. doi: 10.1177/0956462413512806. [PubMed: 24287028].
  • 12. Asnafi S, Sharifi V, Tehranidoost M. Negative priming in amphetamine psychosis. Psychiatry Res. 2013;210(1):263-7. doi: 10.1016/j.psychres.2013.05.027. [PubMed: 23773294].
  • 13. Eghtedari A, Shariat V, Farahani H. [Cognitive functions in patients with methamphetamine-induced psychosis in comparison with a healthy control group]. Adv Cogn Sci. 2012;13(4):19-26. Persian.
  • 14. Barati M, Ahmadpanah M, Soltanian AR. Prevalence and factors associated with methamphetamine use among adult substance abusers. J Res Health Sci. 2014;14(3):221-6. [PubMed: 25209911].
  • 15. Morasco BJ, O'Neil ME, Duckart JP, Ganzini L. Comparison of health service use among veterans with methamphetamine versus alcohol use disorders. J Addict Med. 2014;8(1):47-52. doi: 10.1097/ADM.0000000000000005. [PubMed: 24365802].
  • 16. Ujike H, Sato M. Clinical features of sensitization to methamphetamine observed in patients with methamphetamine dependence and psychosis. Ann N Y Acad Sci. 2004;1025:279-87. doi: 10.1196/annals.1316.035. [PubMed: 15542728].
  • 17. Hellem TL, Lundberg KJ, Renshaw PF. A review of treatment options for co-occurring methamphetamine use disorders and depression. J Addict Nurs. 2015;26(1):14-23. quiz E1. doi: 10.1097/JAN.0000000000000058. [PubMed: 25761159]. [PubMed Central: PMC5510330].
  • 18. Moon K, Albuquerque FC, Mitkov M, Ducruet AF, Wilson DA, Crowley RW, et al. Methamphetamine use is an independent predictor of poor outcome after aneurysmal subarachnoid hemorrhage. J Neurointerv Surg. 2015;7(5):346-50. doi: 10.1136/neurintsurg-2014-011161. [PubMed: 24780822].
  • 19. Yew KL, Go CS, Razali F, Rajendran P, Ooi PS, Anum A. Methamphetamine-associated reversible cardiomyopathy and stroke risk. Eur Rev Med Pharmacol Sci. 2014;18(17):2403-4. [PubMed: 25268081].
  • 20. Niemi-Pynttari JA, Sund R, Putkonen H, Vorma H, Wahlbeck K, Pirkola SP. Substance-induced psychoses converting into schizophrenia: a register-based study of 18,478 Finnish inpatient cases. J Clin Psychiatry. 2013;74(1):e94-9. doi: 10.4088/JCP.12m07822. [PubMed: 23419236].
  • 21. Li H, Lu Q, Xiao E, Li Q, He Z, Mei X. Methamphetamine enhances the development of schizophrenia in first-degree relatives of patients with schizophrenia. Can J Psychiatry. 2014;59(2):107-13. doi: 10.1177/070674371405900206. [PubMed: 24881129]. [PubMed Central: PMC4079234].
  • 22. Pluddemann A, Dada S, Parry CD, Kader R, Parker JS, Temmingh H, et al. Monitoring the prevalence of methamphetamine-related presentations at psychiatric hospitals in Cape Town, South Africa. Afr J Psychiatry (Johannesbg). 2013;16(1):45-9. [PubMed: 23417636].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments